Form 4 KALOBIOS PHARMACEUTICALS For: Nov 24 Filed by: Shkreli Martin
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Wall Street ends down as oil prices, Treasury yields rise
- BTIG’s Krinsky warns 2000-like signals are mounting
- HSBC remains max bullish on stocks, tells investors to lean into tech
- Analyst explains why the midterm outcome is a “fundamental non-event”
- Oil settles up around 4% as Iran's president vows to never surrender
- On Holding sets 2029 financial targets, authorizes $1B share buyback
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Nasdaq reaches record high close, AI stocks rally
- Elmet Group signs tungsten offtake deal with Hemerdon Mine
- Meta bull case increasingly playing out, Mizuho says
KaloBios Pharma (KBIO) Could Drop 50% By Early Next Week: Tim Sykes
November 24, 2015 12:46 PM ESTTim Sykes thinks KaloBios Pharma (NASDAQ: KBIO) could drop 50% by early next week, according to the New York... More
KaloBios Pharma (KBIO) CEO Shkreli Bought 5,000 More Shares
November 24, 2015 11:23 AM ESTKaloBios Pharma (NASDAQ: KBIO) CEO Martin Shkreli bought more shares.
Shkreli purchased 5,000 shares on November 24 at $38.15 apiece, according to a Form 4 filed Tuesday.
... More